Presence of CRF09_cpx and complex CRF02_AG/CRF09_cpx recombinant HIV type 1 strains in Côte d'Ivoire, West Africa

AIDS Research and Human Retroviruses

Volumn 21, Issue 7, 2005, Pages 667-672

  Toni, Thomas ^a,b   Adjé Touré, Christiane ^c   Vidal, Nicole ^d   Minga, Albert ^a   Huet, Charlotte ^a   Borger, Marie Yolande ^c   Recordon Pinson, Patricia ^b   Masquelier, Bernard ^b   Nolan, Monica ^c,e   Nkengasong, John ^f   Fleury, Hervé J ^b   Delaporte, Eric ^d   Peeters, Martine ^d,g  

^a Programme PAC CI   (Côte d’Ivoire)

^b University Victor Segalen   (France)

^c Project RETRO CI Abidjan   (Côte d’Ivoire)

^d INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^g UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DNA; PROTEINASE; RNA DIRECTED DNA POLYMERASE; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

ADOLESCENT; AFRICA; ARTICLE; CHILD; CLINICAL ARTICLE; COTE D'IVOIRE; GENE MUTATION; GENETIC VARIABILITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFANT; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS GENOME; VIRUS RECOMBINANT; VIRUS RESISTANCE;

COTE D'IVOIRE; GENE PRODUCTS, ENV; GENE PRODUCTS, POL; HIV-1; MOLECULAR SEQUENCE DATA; SPECIES SPECIFICITY;

EID: 23444439149     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2005.21.667     Document Type: Article

References (16)

1. McCutchan FE: Understanding the genetic diversity of HIV-1. AIDS 2000;14(Suppl. 3):S31-44.
2. Peeters M and Sharp PM: Genetic diversity of HIV-1: The moving target. AIDS 2000;14(Suppl. 3):S129-140.
3. Peeters M, Toure-Kane C, and Nkengasong JN: Genetic diversity of HIV in Africa: Impact on diagnosis, treatment, vaccine development and trials. AIDS 2003;17(18):2547-2560.
4. Mamadou S, Vidal N, Montavon C, Ben A, Djibo A, Rabiou S, Soga G, Delaporte E, Mboup S, and Peeters M: Emergence of complex and diverse CRF02_AG/CRF06_cpx recombinant HIV type 1 strains in Niger, West Africa. AIDS Res Hum Retroviruses 2003; 19(1):77-82.
5. Toni TD, Recordon-Pinson P, Minga A, Ekouevi D, Bonard D, Bequet L, Huet C, Chenal H, Rouet F, Dabis F, Lafon ME, Salamon R, Masquelier B, and Fleury HJ: Presence of key drug resistance mutations in isolates from untreated patients of Abidjan, Côte d'Ivoire: ANRS 1257 study. AIDS Res Hum Retroviruses 2003; 19(8):713-717.
6. Toni T, Masquelier B, Bonard D, Faure M, Huet C, Caumont A, Roques P, Dabis F, Salamon R, Fleury H; Primo-CI/PAC-CI Study Group: Primary HIV-1 drug resistance in AIDS 2002;16(3):488-491.
7. Montavon C, Vergne L, Bourgeois A, Mpoudi-Ngole E, Malonga-Mouellet G, Butel C, Toure-Kane C, Delaporte E, and Peeters M: Identification of a new circulating recombinant form of HIV type 1, CRF11_cpx, involving subtypes A, G, J, and CRF01-AE, in Central Africa. AIDS Res Hum Retroviruses 2002;18(3):231-236.
8. Montavon C, Toure-Kane C, Nkengasong JN, Vergne L, Hertogs K, Mboup S, Delaporte E, and Peeters M: CRF06_cpx: A new circulating recombinant form of HIV-1 in West Africa involving sub-types A, G, K, and J. J Acquir Immune Defic Syndr 2002;29(5): 522-530.
9. Thompson JD, Higgins DG, and Gibson TJ: CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-4680.
10. McCutchan FE, Sankale JL, M'Boup S, Kim B, Tovanabutra S, Hamel DJ, Brodine SK, Kanki PJ, and Birx DL: HIV type 1 circulating recombinant form CRF09_cpx from west Africa combines subtypes A, F, G, and may share ancestors with CRF02_AG and Z321. AIDS Res Hum Retroviruses 2004;20(8):819-826.
11. Ouedraogo-Traore R, Montavon C, Sanou T, Vidal N, Sangare L, Sanou I, Soudre R, Mboup S, Delaporte E, and Peeters M: CRF06_cpx is the predominant HIV-1 variant in AIDS patients from Ouagadougou, the capital city of Burkina Faso. AIDS 2003; 17(3):441-442.
12. Yang R, Kusagawa S, Zhang C, Xia X, Ben K, and Takebe Y: Identification and characterization of a new class of human immunodeficiency virus type I recombinants comprised of two circulating recombinant forms, CRF07_BC and CRF08_BC, in China. J Virol 2003;77(1):685-695.
13. Fultz PN: HIV-1 superinfections: Omens for vaccine efficacy? AIDS 2004;18(1):115-119.
14. Fang G, Weiser B, Kuiken C, Philpott SM, Rowland-Jones S, Plummer F, Kimani J, Shi B, Kaul R, Bwayo J, Anzala O, and Burger H: Recombination following superinfection by HIV-1. AIDS 2004;18(2):153-159.
15. Moutouh L, Corbeil J, and Richman DD: Recombination leads to the rapid emergence of HIV-1 dually resistant mutants under selective drug pressure. Proc Natl Acad Sci USA 1996;93:6106-6111.
16. Chakraborty B, Kiser P, Rangel HR, Weber J, Mirza M, Marotta ML, Asaad R, Rodriguez B. Valdez H, Lederman MM, and Quinones-Mateu ME: Can HIV-1 superinfection compromise antiretroviral therapy? AIDS 2004;18(1):132-134.